Recently, a transcription factor gene, SRY-box transcription factor 4 (SOX4), and the cyclin-dependent kinase inhibitor 2A (CDKN2A), have attracted the attention of researchers as they may play essential roles in lymphoma oncogenesis [11,12,13]. This evidence concerns the gene SOX4 and lymphoma.